1.
The Community shall purchase the following strains of foot-and-mouth disease antigen:
–
A22 Iraq: 2 000 000 doses
–
C1: 5 000 000 doses
–
ASIA 1: 5 000 000 doses
1.
up to a maximum cost of ECU 2,4 million.
2.
The antigen mentioned in paragraph 1 shall be supplied by Rhône Mérieux.
3.
The Community shall make arrangements for formulation, production, bottling and distribution of vaccines against foot-and-mouth disease produced from antigens mentioned in paragraph 2 initially up to a maximum cost of ECU 1,5 million.
4.
The action referred to in paragraph 3 shall be organized by the Commission.